A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients

Breast Cancer Research and Treatment

Volumn 130, Issue 2, 2011, Pages 425-436

  Didraga, M A ^a   Van Beers, E H ^a   Joosse, S A ^a   Brandwijk, K I M ^a   Oldenburg, R A ^b   Wessels, L F A ^a   Hogervorst, F B L ^a   Ligtenberg, M J ^c   Hoogerbrugge, N ^c   Verhoef, S ^a   Devilee, P ^a   Nederlof, P M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; CGH; Formalin fixed paraffin embedded; Hereditary cancer; Primary tumors

Indexed keywords

ADULT; ARRAY COMPARATIVE GENOMIC HYBRIDIZATION; ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER TISSUE; CHROMOSOME 22; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MORPHOLOGY; ONCOGENE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; CHROMOSOME DUPLICATION; CHROMOSOMES, HUMAN, PAIR 22; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENES, NEOPLASM; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS;

EID: 82955242446     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1357-x     Document Type: Article

References (55)

1. World Health Organization (2004) The global burden of disease: 2004 update
2. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71 (Pubitemid 24345325)
3. Wooster R, Neuhausen SL, Mangion J et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090 (Pubitemid 24325690)
4. Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792 (Pubitemid 26004412)
5. Meijers-Heijboer H, van den Ouweland A, Klijn Jetal (2002)Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100-del C in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31: 55-59
6. Thompson D, Duedal S, Kirner J et al (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97:813-822 (Pubitemid 40909124)
7. Seal S, Thompson D, Renwick A et al (2006) Truncating muta-tions in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38:1239-1241 (Pubitemid 44646283)
8. Rahman N, Seal S, Thompson D et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer sus-ceptibility gene. Nat Genet 39:165-167 (Pubitemid 46184346)
9. Cox A, Dunning AM, Garcia-Closas M et al (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39:352-358 (Pubitemid 46328496)
10. Easton DF, Pooley KA, Dunning AM et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093 (Pubitemid 47014426)
11. Stacey SN, Manolescu A, Sulem P et al (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40:703-706 (Pubitemid 351748861)
12. Chen J, Lindblom P, Lindblom A (1998) A study of the PTEN/MMAC1 gene in 136 breast cancer families. Hum Genet 102: 124-125
13. Leggett BA, Young JP, Barker M (2003) Peutz-Jeghers syn-drome: genetic screening. Expert Rev Anticancer Ther 3:518-524
14. Pharoah PD, Guilford P, Caldas C (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121:1348-1353 (Pubitemid 33140452)
15. Borresen AL, Andersen TI, Garber J et al (1992) Screening for germ line TP53 mutations in breast cancer patients. Cancer Res 52:3234-3236
16. Evans DG, Birch JM, Thorneycroft M, Mc Gown G, Lalloo F, Varley JM (2002) Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome. J Med Genet 39:941-944 (Pubitemid 36009160)
17. Lalloo F, Varley J, Moran A et al (2006) BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer 42:1143-1150
18. Malkin D, Li FP, Strong LC et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238 (Pubitemid 120031831)
19. Turnbull C, Rahman N (2008) Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 9:321-345
20. Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103-105 (Pubitemid 46209856)
21. Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665-676 (Pubitemid 39215065)
22. Kainu T, Juo SH, Desper R et al (2000) Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci USA 97:9603-9608 (Pubitemid 30650822)
23. Huusko P, Juo SH, Gillanders E et al (2004) Genome-wide scanning for linkage in Finnish breast cancer families. Eur J Hum Genet 12:98-104 (Pubitemid 38263553)
24. Thompson D, Szabo CI, Mangion J et al (2002) Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromo-some 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci USA 99:827-831 (Pubitemid 34106595)
25. Smith P, Mc Guffog L, Easton DF et al (2006) A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 45:646-655 (Pubitemid 43727152)
26. Burwinkel B, Shanmugam KS, Hemminki K et al (2006) Tran-scription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer 6:268-272
27. Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA (2007) Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3:e42-e47
28. Ponder BA, Antoniou A, Dunning A, Easton DF, Pharoah PD (2005) Polygenic inherited predisposition to breast cancer. Cold Spring Harb Symp Quant Biol 70:35-41 (Pubitemid 44124855)
29. Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273:1516-1517 (Pubitemid 26301653)
30. Oldenburg RA, Kroeze-Jansema KH, Houwing-Duistermaat JJ et al (2008) Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus. Genes Chromosomes Cancer 47:947-956
31. Cui J, Antoniou AC, Dite GS et al (2001) After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet 68:420-431 (Pubitemid 32147811)
32. Antoniou AC, Pharoah PD, Mc Mullan G et al (2002) A com-prehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86:76-83 (Pubitemid 34146344)
33. Pinkel D, Segraves R, Sudar D et al (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211 (Pubitemid 28455458)
34. Curtis C, Lynch AG, Dunning MJ et al (2009) The pitfalls of platform comparison: DNA copy number array technologies assessed. BMC Genomics 10:588-610
35. Wessels LF,van Welsem T, Hart AA, Van't Veer LJ, Reinders MJ, Nederlof PM (2002) Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profilefor BRCA1 tumors. Cancer Res 62:7110-7117
36. van Beers EH, van Welsem T, Wessels LF et al (2005) Com-parative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. Cancer Res 65:822-827 (Pubitemid 40216440)
37. Jonsson G, Naylor TL, Vallon-Christersson J et al (2005) Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res 65: 7612-7621 (Pubitemid 41297233)
38. Alvarez S, Diaz-Uriarte R, Osorio A et al (2005) A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation. Clin Cancer Res 11:1146-1153 (Pubitemid 40175764)
39. Gronwald J, Jauch A, Cybulski C et al (2005) Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer 114:230-236 (Pubitemid 40194291)
40. Hu X, Stern HM, Ge L et al (2009) Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res 7:511-522
41. Joosse SA, van Beers EH, Tielen IH et al (2009) Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH. Breast Cancer Res Treat 116: 479-489
42. Joosse SA, Brandwijk KIM, Devilee P, Wesseling J, Hogervorst FB, Verhoef S, Nederlof PM (2010) Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH. Breast Cancer Res Treat. PMID: 20614180
43. van Beers EH, Joosse SA, Ligtenberg MJ et al (2006) A multiplex PCR predictor for a CGH success of FFPE samples. Br J Cancer 94:333-337 (Pubitemid 43151556)
44. Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H et al (2006) Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping. Clin Cancer Res 12:1693-1700
45. Oldenburg RA, Kroeze-Jansema K, Kraan J et al (2003) The CHEK2*1100del C variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families. Cancer Res 63: 8153-8157 (Pubitemid 37549462)
46. Joosse SA, van Beers EH, Nederlof PM (2007) Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material. BMC Cancer 7:43-53
47. Picard F, Robin S, Lavielle M, Vaisse C, Daudin JJ (2005) A statistical approach for array CGH data analysis. BMC Bioin-formatics 6:27-40
48. Tibshirani R, Hastie T, Narasimhan B, Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expres-sion. Proc Natl Acad Sci US A 99:6567-6572 (Pubitemid 34526173)
49. Meindl A, Hellebrand H, Wiek C et al (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42:410-414
50. Stratton MR, Ford D, Neuhasen S et al (1994) Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 7:103-107 (Pubitemid 24232389)
51. Oldenburg RA, Meijers-Heijboer H, Cornelisse CJ, Devilee P (2007) Genetic susceptibility for breast cancer: how many more genes to be found? Crit Rev Oncol Hematol 63:125-149 (Pubitemid 46990913)
52. Rouleau E, Lefol C, Tozlu S et al (2007) High-resolution oli-gonucleotide array-CGH applied to the detection and character-ization of large rearrangements in the hereditary breast cancer gene BRCA1. Clin Genet 72:199-207 (Pubitemid 47300022)
53. Tirkkonen M, Kainu T, Loman N et al (1999) Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer. Genes Chromosomes Cancer 24:56-61 (Pubitemid 28544463)
54. Melchor L, Honrado E, Huang J et al (2007) Estrogen receptor status could modulate the genomic pattern in familial and spo-radic breast cancer. Clin Cancer Res 13:7305-7313
55. Rosa-Rosa JM, Pita G, Gonzalez-Neira A et al (2009) A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer. Breast Cancer Res Treat 118:151-159